Baxter Phillips
Operationeel Directeur bij LOBE SCIENCES LTD.
Vermogen: 11 560 $ op 31-05-2024
Actieve functies van Baxter Phillips
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LOBE SCIENCES LTD. | Directeur/Bestuurslid | 03-10-2022 | - |
Operationeel Directeur | 07-06-2023 | - | |
Cambridge Allergy Ltd.
Cambridge Allergy Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Allergy Ltd. operates as a biopharmaceutical company which manufactures medicines for food allergies. The company was founded by Sherden Timmins, Andrew Clark, and Pamela Ewan on December 7, 2015 and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | 16-10-2018 | - |
Independent Dir/Board Member | - | - | |
Algemeen Directeur | 16-10-2018 | - | |
Altemia & Co. LLC
Altemia & Co. LLC Pharmaceuticals: OtherHealth Technology Part of Clearway Global LLC, Altemia & Co. LLC is a medical food company. The company is based in Stuart, FL. Altemia & Co. was acquired by Lobe Sciences Ltd. on April 29, 2024 for $1.01 million. | President | - | - |
Loopbaan van Baxter Phillips
Eerdere bekende functies van Baxter Phillips
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Algemeen Directeur | 01-10-2015 | 01-10-2017 |
President | 01-10-2015 | 01-10-2017 | |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Investor Relations Contact | 13-11-2013 | 27-05-2015 |
Corporate Officer/Principal | 13-11-2013 | 01-10-2015 | |
OSTEOLOGIX HOLDINGS PLC | Public Communications Contact | 06-05-2010 | 01-08-2011 |
Corporate Officer/Principal | 01-06-2007 | 06-05-2010 |
Opleiding van Baxter Phillips
Hampden-Sydney College | Undergraduate Degree |
Mason School of Business of The College of William & Mary | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 6 |
Ierland | 2 |
Verenigd Koninkrijk | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Executive Officer | 2 |
President | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
LOBE SCIENCES LTD. | Process Industries |
Bedrijven in privébezit | 5 |
---|---|
Osteologix Holdings Plc
Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Osteologix Holdings Plc engaged in the development of innovative pharmaceuticals for the treatment and prevention of bone and joint tissues diseases. The company was founded in October 2004 and was headquartered in Dublin, Ireland. | Health Technology |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Health Technology |
Cambridge Allergy Ltd.
Cambridge Allergy Ltd. Pharmaceuticals: MajorHealth Technology Cambridge Allergy Ltd. operates as a biopharmaceutical company which manufactures medicines for food allergies. The company was founded by Sherden Timmins, Andrew Clark, and Pamela Ewan on December 7, 2015 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Altemia & Co. LLC
Altemia & Co. LLC Pharmaceuticals: OtherHealth Technology Part of Clearway Global LLC, Altemia & Co. LLC is a medical food company. The company is based in Stuart, FL. Altemia & Co. was acquired by Lobe Sciences Ltd. on April 29, 2024 for $1.01 million. | Health Technology |
- Beurs
- Insiders
- Baxter Phillips
- Ervaring